The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000038.6(APC):c.715G>C (p.Ala239Pro)

CA047113

220329 (ClinVar)

Gene: APC
Condition: familial adenomatous polyposis 1
Inheritance Mode: Autosomal dominant inheritance
UUID: cfd3f93d-673f-4e46-ba4f-6e1c877b3c0b
Approved on: 2023-02-18
Published on: 2023-03-14

HGVS expressions

NM_000038.6:c.715G>C
NM_000038.6(APC):c.715G>C (p.Ala239Pro)
NC_000005.10:g.112792515G>C
CM000667.2:g.112792515G>C
NC_000005.9:g.112128212G>C
CM000667.1:g.112128212G>C
NC_000005.8:g.112156111G>C
NG_008481.4:g.104995G>C
ENST00000257430.9:c.715G>C
ENST00000257430.8:c.715G>C
ENST00000507379.5:c.676-8764G>C
ENST00000508376.6:c.715G>C
ENST00000508624.5:c.715G>C
ENST00000512211.6:c.715G>C
NM_000038.5:c.715G>C
NM_001127510.2:c.715G>C
NM_001127511.2:c.676-8764G>C
NM_001354895.1:c.715G>C
NM_001354896.1:c.715G>C
NM_001354897.1:c.745G>C
NM_001354898.1:c.640G>C
NM_001354899.1:c.646-8764G>C
NM_001354900.1:c.538G>C
NM_001354901.1:c.538G>C
NM_001354902.1:c.745G>C
NM_001354903.1:c.715G>C
NM_001354904.1:c.640G>C
NM_001354905.1:c.538G>C
NM_001354906.1:c.-321G>C
NM_001127510.3:c.715G>C
NM_001127511.3:c.676-8764G>C
NM_001354895.2:c.715G>C
NM_001354896.2:c.715G>C
NM_001354897.2:c.745G>C
NM_001354898.2:c.640G>C
NM_001354899.2:c.646-8764G>C
NM_001354900.2:c.538G>C
NM_001354901.2:c.538G>C
NM_001354902.2:c.745G>C
NM_001354903.2:c.715G>C
NM_001354904.2:c.640G>C
NM_001354905.2:c.538G>C
NM_001354906.2:c.-321G>C
More

Benign

Met criteria codes 3
BS1 BS2 BP1
Not Met criteria codes 1
BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The c.715G>C variant in APC is a missense variant predicted to cause substitution of alanine by proline at amino acid 239 (p.Ala239Pro). This variant has been observed in ≥ 35 heterozygous individuals with no features or family history of FAP, worth ≥ 10 healthy individual points (BS2; Ambry, Invitae internal data). The highest allele frequency of this variant in gnomAD v2.1.1 (non-cancer) is 0.0002269 in East Asian population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) threshold (≥ 0.00001) for BS1 (BS1). Finally, APC is defined by the HCCP VCEP as a gene for which primarily truncating variants are known to cause disease (BP1). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BS1, BS2, BP1. (VCEP specifications version 1; date of approval 12/12/2022).
Met criteria codes
BS1
The highest population minor allele frequency of the variant c.715G>C in gnomAD v2.1.1 (non-cancer) is 0.0002269 (4/17632 alleles) in East Asian population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel threshold (≥ 0.00001) for BS1.
BS2
This variant has been observed in ≥ 35 heterozygous individuals with no features or family history of FAP meeting ≥ 10 healthy individual points (BS2; Ambry, Invitae).
BP1
APC, in which the variant was identified, is defined by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP as a gene for which primarily truncating variants are known to cause disease (BP1).
Not Met criteria codes
BP4
The results from ≥2 in silico splicing predictors (SpliceAI, varSEAK) support that this variant does not affect splicing (BP4 not applicable for missense variant).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.